Useful for general screening in contexts of compliance and/or abuse. A screen with reflex testing is the preferred method for ruling out drug exposure. This test does not distinguish between the delta-8 and delta-9 forms of THC or their metabolites.
Enzyme Immunoassay/Gas Chromatography-Flame Ionization Detection/Gas Chromatography-Mass Spectrometry/Liquid Chromatography-Tandem Mass Spectrometry
New York DOH Approval Status
Transfer 8 mL urine with no additives or preservatives in ARUP Standard Transport Tubes. (Min: 4 mL)
Specimens exposed to repeated freeze/thaw cycles.
Ambient: 1 week; Refrigerated: 1 month; Frozen: 1 month
Effective August 17, 2015
|Drugs Covered and Cutoff Concentrations
|THC (Cannabinoids)||20 ng/mL|
|MDMA (Ecstasy)||500 ng/mL|
The absence of expected drug(s) and/or drug metabolite(s) may indicate noncompliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, diluted/adulterated urine, or limitations of testing. The concentration at which the screening test can detect a drug or metabolite varies within a drug class. Specimens for which drugs or drug classes are detected by the screen are reflexed to a second, more specific technology (GC/MS, GC/FID, and/or LC-MS/MS). The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.
For medical purposes only; not valid for forensic use.
Oxycodone results are reported with the opiates results. MDMA results are reported with the amphetamines results. The following opioids are not detected in this test: fentanyl, buprenorphine, meperidine, tramadol, and tapentadol. A comprehensive panel that includes these opioids is available or individual opioid testing can be ordered. Refer to aruplab.com for test information.
If the specimen screens positive, then Confirmation/Quantitation by GC/MS, GC/FID, and/or LC-MS/MS will be added to confirm result. Additional charges apply.
To order testing for individual opioids, refer to Fentanyl and Metabolite - Confirmation/Quantitation - Urine (ARUP test code 0092570), Buprenorphine and Metabolites - Confirmation/Quantitation - Urine (ARUP test code 2010092), Meperidine and Metabolite Quantitative, Urine (ARUP test code 3000248), Tramadol and Metabolites - Confirmation/Quantitation - Urine (ARUP test code 2002736). For the comprehensive panel, refer to Pain Management Drug Panel by High-Resolution Time-of-Flight Mass Spectrometry and Enzyme Immunoassay, Urine (ARUP test code 2007479).
80307; if reflexed, add 80320; 80325; 80345; 80346; 80349; 80353; 80358; 80359; 80361; 80365; 80367; 83992 (Reflexed Alt Code: G0480 )
|Component Test Code*||Component Chart Name||LOINC|
|0090406||CDASU 9A Comments||48767-8|
|0092191||Amphetamines, Urn, Screen||19261-7|
|0092192||Cocaine, Urn, Screen||19359-9|
|0092193||Opiates, Urn, Screen||19300-3|
|0092194||Phencyclidine, Urn, Screen||19659-2|
|0092195||THC, Urn, Screen||19292-2|
|0092196||Barbiturates, Urn, Screen||19270-8|
|0092197||Benzodiazepines, Urn, Screen||14316-4|
|0092198||Propoxyphene, Urn, Screen||19429-0|
|0092199||Methadone, Urn, Screen||19550-3|
|0092400||Alcohol, Urn, Screen||46983-3|
- Alcohol, Urine
- Amphetamines, Urine
- Barbiturates, Urine;
- Benzodiazepines, Urine
- Cocaine, Urine
- Creatinine, Urine
- Marijuana, Urine
- Methadone, Urine
- Opiates, Urine
- Pain Management
- Phencyclidine, Urine
- Propoxyphene, Urine